Hims & Hers Health slides 14% after earnings miss, guidance cut (HIMS:NYSE)

SA Spotlight uses AI to summarize content published on Seeking Alpha. All summaries are reviewed by human editors prior to publication.

Shares of Hims & Hers Health (HIMS), a consumer-focused digital health and telehealth platform, tumbled almost 14% today after the company reported a quarterly earnings miss and reduced its full-year guidance. In morning trading, the stock fell to $19.76, a decline of $3.18 from its previous

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.